Montana’s plan to become an experimental medical hub just pushed forward
MIT Tech ReviewPaywall
Read Full Article at MIT Tech Review →Ad Slot — In-Article (728x90)
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval.
This is a summary. For the full story, read the original article at MIT Tech Review.
Original source: MIT Tech Review